The arrival of the drug in Oz is creating significant excitement within the medical community. This novel dual medication – acting on both GLP-1 and GIP receptors – presents a potentially effective approach for https://australianpeptidestore.co/bpc-157-10mg-research-peptide-australian-peptide-store/